메뉴 건너뛰기




Volumn 43, Issue 11, 2009, Pages 997-1002

In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment

Author keywords

Dyslipidemia; Glucose intolerance; Olanzapine; Schizophrenia; Signal detection method; Ziprasidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLANZAPINE; TRIACYLGLYCEROL; ZIPRASIDONE;

EID: 67649386886     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.01.010     Document Type: Article
Times cited : (18)

References (21)
  • 2
    • 0842348094 scopus 로고    scopus 로고
    • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity
    • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596-601.
    • (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care , vol.27 , pp. 596-601
  • 3
    • 33244486544 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association Professional Practice Committee
    • American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl. 1):S43-8.
    • (2006) Diabetes Care , vol.29 , Issue.SUPPL. 1
  • 4
    • 30144440088 scopus 로고    scopus 로고
    • Drugs and the treatment of psychiatric disorders, antipsychotic and antimanic agents
    • Hardman J.P., Limbird L.E., and Gillman A.G. (Eds), McGraw Hill, New York [chapter 18]
    • Baldessarini R.J., and Tarzi F.I. Drugs and the treatment of psychiatric disorders, antipsychotic and antimanic agents. In: Hardman J.P., Limbird L.E., and Gillman A.G. (Eds). Goodman and Gillman's the pharmacological basis of therapeutics. 11th ed. (2005), McGraw Hill, New York [chapter 18]
    • (2005) Goodman and Gillman's the pharmacological basis of therapeutics. 11th ed.
    • Baldessarini, R.J.1    Tarzi, F.I.2
  • 5
  • 6
    • 0035897696 scopus 로고    scopus 로고
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Executive Summary of the Third Report of the National Cholesterol Education Program NCEP
    • Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001;285:2486-97.
    • (2001) Journal of the American Medical Association , vol.285 , pp. 2486-2497
  • 8
    • 33646681652 scopus 로고    scopus 로고
    • A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms
    • Kinon B.J., Lipkovich I., Edwards S.B., Adams D.H., Ascher-Svanum H., and Siris S.G. A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. Journal of Clinical Psychopharmacology 26 (2006) 157-162
    • (2006) Journal of Clinical Psychopharmacology , vol.26 , pp. 157-162
    • Kinon, B.J.1    Lipkovich, I.2    Edwards, S.B.3    Adams, D.H.4    Ascher-Svanum, H.5    Siris, S.G.6
  • 9
    • 0034977454 scopus 로고    scopus 로고
    • How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors
    • Kraemer H.C., Stice E., Kazdin A., Offord D., and Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry 158 (2001) 848-856
    • (2001) American Journal of Psychiatry , vol.158 , pp. 848-856
    • Kraemer, H.C.1    Stice, E.2    Kazdin, A.3    Offord, D.4    Kupfer, D.5
  • 11
    • 25144456112 scopus 로고    scopus 로고
    • Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
    • Lieberman J.A., Stroup T.S., McEvoy J.P., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353 (2005) 1209-1223
    • (2005) New England Journal of Medicine , vol.353 , pp. 1209-1223
    • Lieberman, J.A.1    Stroup, T.S.2    McEvoy, J.P.3
  • 13
    • 0037016001 scopus 로고    scopus 로고
    • Differentiation between obesity and insulin resistance in the association with C-reactive protein
    • McLaughlin T., Abbasi F., Lamendola C., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106 (2002) 2908-2912
    • (2002) Circulation , vol.106 , pp. 2908-2912
    • McLaughlin, T.1    Abbasi, F.2    Lamendola, C.3
  • 14
    • 0003135770 scopus 로고    scopus 로고
    • Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults
    • National Institutes of Health, Bethesda, MD: National Institutes of Health, United States Department of Health and Human Services;
    • National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the Evidence Report. Bethesda, MD: National Institutes of Health, United States Department of Health and Human Services; 1998.
    • (1998) the Evidence Report
  • 15
    • 2342430250 scopus 로고    scopus 로고
    • Obesity, insulin resistance, and cardiovascular disease
    • Reaven G.M. Obesity, insulin resistance, and cardiovascular disease. Recent Progress in Hormone Research 59 (2004) 207-223
    • (2004) Recent Progress in Hormone Research , vol.59 , pp. 207-223
    • Reaven, G.M.1
  • 16
    • 14744293406 scopus 로고    scopus 로고
    • Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals
    • Reaven G.M. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinology and Metabolism Clinics of North America 34 (2005) 49-62
    • (2005) Endocrinology and Metabolism Clinics of North America , vol.34 , pp. 49-62
    • Reaven, G.M.1
  • 17
    • 0024160877 scopus 로고
    • Role of insulin resistance in human disease
    • Reaven G.M. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
    • (1988) Diabetes , vol.37 , pp. 1595-1607
    • Reaven, G.M.1
  • 18
    • 0037418543 scopus 로고    scopus 로고
    • Identifying the overweight patient who will benefit the most by losing weight
    • Reaven G.M. Identifying the overweight patient who will benefit the most by losing weight. Annals of Internal Medicine 138 (2003) 420-423
    • (2003) Annals of Internal Medicine , vol.138 , pp. 420-423
    • Reaven, G.M.1
  • 19
    • 0033527030 scopus 로고    scopus 로고
    • Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (VA-HIT)
    • Rubins H.B., Robins S.J., Collins D., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (VA-HIT). New England Journal of Medicine 341 (2005) 410-418
    • (2005) New England Journal of Medicine , vol.341 , pp. 410-418
    • Rubins, H.B.1    Robins, S.J.2    Collins, D.3
  • 20
    • 23344434378 scopus 로고    scopus 로고
    • Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia
    • Simpson G.M., Weiden P., Pigott T., Murray S., Siu C.O., and Romano S.J. Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia. American Journal of Psychiatry 162 (2005) 1535-1538
    • (2005) American Journal of Psychiatry , vol.162 , pp. 1535-1538
    • Simpson, G.M.1    Weiden, P.2    Pigott, T.3    Murray, S.4    Siu, C.O.5    Romano, S.J.6
  • 21
    • 0033984997 scopus 로고    scopus 로고
    • Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy, nondiabetic individuals
    • Yeni-Komshian H., Carantoni M., Abbasi F., and Reaven G.M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy, nondiabetic individuals. Diabetes Care 23 (2000) 171-175
    • (2000) Diabetes Care , vol.23 , pp. 171-175
    • Yeni-Komshian, H.1    Carantoni, M.2    Abbasi, F.3    Reaven, G.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.